The historical rank and industry rank for Cosmos Health's OCF Margin % or its related term are showing as below:
STU:V67A'
s OCF Margin % Range Over the Past 10 Years
Min: -31.47 Med: -17.47 Max: -4.19
Current: -13.38
During the past 13 years, the highest OCF Margin % of Cosmos Health was -4.19%. The lowest was -31.47%. And the median was -17.47%.
STU:V67A's OCF Margin % is ranked worse than 87.29% of 118
companies
in the Medical Distribution industry
Industry Median: 2.24
vs STU:V67A: -13.38
Cosmos Health OCF Margin % Related Terms
Cosmos Health OCF Margin % Historical Data
* Premium members only.
The historical data trend for Cosmos Health's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STU:V67A vs HKPD, VNOV, SNYR: OCF Margin % Comparison
For the Medical Distribution subindustry, Cosmos Health's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cosmos Health OCF Margin % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Cosmos Health's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Cosmos Health's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cosmos Health (STU:V67A) has a OCF Margin % of -5.95% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Cosmos Health and its competitors. According to the industry distribution chart, Cosmos Health ranks #103 out of 118 companies in the Medical Distribution industry, placing it in the top 87.3%.
Is Cosmos Health's OCF Margin % too high?
Cosmos Health's current OCF Margin % is -5.95%. Based on the distribution chart, Cosmos Health ranks #103 out of 118 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, Cosmos Health has a GF Score™ of 29/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Cosmos Health's OCF Margin % compare to HKPD and VNOV?
According to the Medical Distribution industry distribution chart, Cosmos Health ranks #103 out of 118 companies for OCF Margin %. This places Cosmos Health in the lower half of its industry. The industry median OCF Margin % is 2.24. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Distribution company?
The median OCF Margin % among Medical Distribution companies is 2.24, based on 118 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Cosmos Health and its competitors. For the Medical Distribution industry, the median OCF Margin % is 2.24 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cosmos Health's current OCF Margin % is -5.95%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cosmos Health stock overvalued right now?
Based on GuruFocus' analysis, Cosmos Health (STU:V67A) is currently considered Possible Value Trap. The stock's GF Value™ is €0.30, compared to a current price of €0.18 — trading 41.3% below its estimated fair value. The current OCF Margin % is -5.95%. Cosmos Health's overall GF Score™ is 29/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Cosmos Health (STU:V67A), the current OCF Margin % is -5.95% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cosmos Health (STU:V67A) Overvalued in 2026?
Based on GuruFocus' analysis, Cosmos Health stock appears to be undervalued.
The current stock price of €0.18 is trading 41.3% below its estimated GF Value™ of €0.30.
GuruFocus considers Cosmos Health to be Possible Value Trap.
Key valuation signals for STU:V67A:
OCF Margin %: -5.95%
GF Value™: €0.30 vs. price of €0.18 (41.3% below fair value)
No single metric tells the full story. See the STU:V67A stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cosmos Health Inc is a diversified, vertically integrated healthcare group, owner of proprietary pharmaceutical and nutraceutical brands, generics, manufacturer and distributor of healthcare products, engaged in research & development of medicines and repurposing drugs as well as operator of a telehealth platform. The company has developed its own proprietary branded nutraceutical products, named 'Sky Premium Life' and 'Mediterranation'. Its product portfolio includes generics and over-the-counter pharmaceutical products, medicines, as well as nutraceuticals and biocides. The company's Reportable segments are Wholesale, Pharma manufacturing, and Nutraceutical and pharmaceuticals, with the majority of revenue generated from the Wholesale segment.
29GF Score
Get the complete analysis for STU:V67A
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:V67A has been successfully added to your 
